Abstract
Filarial nematodes are parasites that have the ability to persist in their hosts for extended periods of time due to the employment of various mechanisms to divert or down-regulate the hosts immune responses. One of these mechanisms is the production of immunomodulatory excretory-secretory (ES) products. This review will discuss the properties of one such product, ES-62, which over the years, has been shown to interact with and modulate the activities of a variety of cells of the immune system including B and T lymphocytes, dendritic cells, macrophages and mast cells. Overall, ES-62 diverts the immune system towards an anti-inflammatory phenotype and consistent with this it has been shown to have therapeutic potential in models of inflammatory disease associated with autoimmunity and allergy.
Keywords: Signal transduction, ES-62, filarial nematode, immunomodulation, immunomodulatory, autoimmunity, Allergy, excretory-secretory, glucosamine-labelled ES-62, N- glycosidase, anti-inflammatory
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Immunomodulatory Properties of ES-62, a Phosphorylcholine - Containing Glycoprotein Secreted by Acanthocheilonema viteae
Volume: 12 Issue: 1
Author(s): Lamyaa Al-Riyami and William Harnett
Affiliation:
Keywords: Signal transduction, ES-62, filarial nematode, immunomodulation, immunomodulatory, autoimmunity, Allergy, excretory-secretory, glucosamine-labelled ES-62, N- glycosidase, anti-inflammatory
Abstract: Filarial nematodes are parasites that have the ability to persist in their hosts for extended periods of time due to the employment of various mechanisms to divert or down-regulate the hosts immune responses. One of these mechanisms is the production of immunomodulatory excretory-secretory (ES) products. This review will discuss the properties of one such product, ES-62, which over the years, has been shown to interact with and modulate the activities of a variety of cells of the immune system including B and T lymphocytes, dendritic cells, macrophages and mast cells. Overall, ES-62 diverts the immune system towards an anti-inflammatory phenotype and consistent with this it has been shown to have therapeutic potential in models of inflammatory disease associated with autoimmunity and allergy.
Export Options
About this article
Cite this article as:
Al-Riyami Lamyaa and Harnett William, Immunomodulatory Properties of ES-62, a Phosphorylcholine - Containing Glycoprotein Secreted by Acanthocheilonema viteae, Endocrine, Metabolic & Immune Disorders - Drug Targets 2012; 12 (1) . https://dx.doi.org/10.2174/187153012799278893
DOI https://dx.doi.org/10.2174/187153012799278893 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Coronary Microvascular and Cardiac Dysfunction Due to Homocysteine Pathometabolism; A Complex Therapeutic Design
Current Pharmaceutical Design Alpha-1-Antichymotrypsin: A Common Player for Type 2 Diabetes and Alzheimer's Disease
Current Diabetes Reviews Systems Biology of Apoptosis and Survival: Implications for Drug Development
Current Pharmaceutical Design Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Current Drug Targets The Mechanism of Calcitriol in Cancer Prevention and Treatment
Current Medicinal Chemistry Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i
Current Vascular Pharmacology PPARγ Agonistic Activity of Sulphonylureas
Endocrine, Metabolic & Immune Disorders - Drug Targets Histamine and Histaminergic Receptors in Colorectal Cancer: From Basic Science to Evidence-based Medicine
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Neurohormones, Rikkunshito and Hypothalamic Neurons Interactively Control Appetite and Anorexia
Current Pharmaceutical Design Prospects for Kinase Activity Modulators in the Treatment of Diabetes and Diabetic Complications
Current Topics in Medicinal Chemistry Catecholamines: Physiological Immunomodulators During Health and Illness
Current Medicinal Chemistry Steroid Hormones and Sleep Regulation
Mini-Reviews in Medicinal Chemistry Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link
Current Neuropharmacology Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System
Current Stem Cell Research & Therapy Editorial [ Hot Topic: Past, Present and Future in the Treatment of Major Psychotic Disorders (Executive Guest Editor: Konstantinos N. Fountoulakis)]
Current Pharmaceutical Design Pro-Oxidant Milieu Blunts Scissors: Insight into Tumor Progression, Drug Resistance, and Novel Druggable Targets
Current Pharmaceutical Design Recent Approaches Targeting Beta-Amyloid for Therapeutic Intervention of Alzheimer's disease
Recent Patents on CNS Drug Discovery (Discontinued) Targeting Nanotechnology and Nutraceuticals in Obesity: An Updated Approach
Current Pharmaceutical Design Diabetes Mellitus: A Potential Target for Stem Cell Therapy
Current Stem Cell Research & Therapy